Live Breaking News & Updates on Schaffer Deroo

Stay updated with breaking news from Schaffer deroo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Frontiers | Systematic Assessment of COVID-19 Pandemic in Bangladesh: Effectiveness of Preparedness in the First Wave

Background: To develop an effective countermeasure and determine our susceptibilities to the outbreak of COVID-19 is challenging for a densely populated developing country like Bangladesh and a systematic review of the disease on a continuous basis is necessary. Methods: Publicly available and globally acclaimed datasets (4 March 2020 – 30 September 2020) from IEDCR, Bangladesh, JHU and ECDC database are used for this study. Visual exploratory data analysis is used and we fitted a polynomial model for the number of deaths. A comparison of Bangladesh scenario over different time points as well as with global perspectives is made. Results: In Bangladesh, the number of active cases had decreased, after reaching a peak, with a constant pattern of death rate at from July to the end of September, 2020. 71% of the cases and 77% of the deceased were males. People aged between 21 to 40 years were most vulnerable to the coronavirus and most of the fatalities (51.49%) were in the 60+ population ....

United States , Bangladesh General , United Kingdom , New Zealand , Kyonggi Do , South Korea , Irkutskaya Oblast , Schaffer Deroo , Cox Bazar , Johns Hopkins University , Second Meeting Of The International Health Regulations , Regional Office For Europe , Bank Announces Tk , Data Tracker Global Health , International Data Rescue , Health Services , Ministry Of Health Family Welfare Bangladesh , Sustainable Development Goals , European Centre For Disease Prevention , Zhuy Association , School College , Institute Of Epidemiology , World Health Organization , Trop Med Int Health , Bangladesh Bank , Front Public Health ,

Frontiers | Assessing Attitude Toward COVID-19 Vaccination in South Korea


2Department of Occupational Health and Safety, Inje University, Gimhae, South Korea
Vaccines are the most effective strategy to safeguard against COVID−19 and it is crucial to assess community acceptance of COVID-19 vaccination. This exploratory study aimed to assess the attitude of immigrants toward the acceptance of COVID-19 vaccines in South Korea. A web-based anonymous study was completed by 463 immigrants. The data were statistically analyzed using a logistic regression model and ANOVA test. On a scale of 0–6, the average attitude toward the COVID-19 vaccination was 4.17 ± 1.73, indicating generally positive attitudes. The proportion of the immigrants who were certain to get COVID-19 vaccination was 55.3%. Only 36.7% reported that the COVID-19 vaccines are safe. Of the immigrants, 72.6% showed high acceptance and 27.4% low acceptance toward the COVID-19 vaccines. Vaccine safety concern was the major predictor for COVID-19 vaccine acceptance. Up-to-date, valid informa ....

United States , Waals Gewest , Jawa Tengah , Kangwon Do , South Korea , Chungcheongbuk Do , Ch Ungch Ong Bukto , Schaffer Deroo , Asia Europe Africa , Institutional Review Board Of Inje University , Prevention Agency , Public Health , J Health Econ , Health Serv , Korea Disease Control , South America , P Value Table , Institutional Review Board , Med Abstract , Crossref Full Text , United Arab , Disease Control , Examining Australian , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு கொரியா , சுங்குசேொங்கிபூக் செய் ,

COVID-19 Vaccine: When Your Kids Can Get It and Everything Else You Should Know


Share
Photo: (Photo : Photo by Gustavo Fring from Pexels)
COVID-19 vaccine trials for adolescents or children 12 and older trials are now underway. But, it may take more months for younger children.
Sources say the COVID-19 vaccine from Moderna is only recommended for adults 18 and over and Pfizer 16 and older. Looking forward, by 2021 spring, children who are 12 years old and older will possibly be allowed to be vaccinated. They also said that this might not be the same for younger ones. 
Around three thousand children aged 12-17 are currently enrolled in the Moderna COVID-19 testing program. According to Dr. Kawsar Talaat, the lead investigator of the Johns Hopkins adult phase 3 research site for Pfizer, Pfizer has only completed the first doses for two thousand children aged 12-15. ....

Sarah Schaffer Deroo , Schaffer Deroo , Johns Hopkins , Kawsar Talaat , Children National Hospital , Gustavo Fring , Emergency Usage , Tom Brady , Daily Routine Includes Reading , His Kids , National Hospital , Covid 19 , Covid 19 Vaccine , Covid 19 Pandemic , Covid 19 Vaccine Trials , சாரா ஶேஃபர் தேரோ , ஶேஃபர் தேரோ , ஜான்ஸ் ஹாப்கின்ஸ் , குழந்தைகள் தேசிய மருத்துவமனை , அவசரம் பயன்பாடு , டோம் பிராடி , அவரது கீட்ஸ் , தேசிய மருத்துவமனை ,